"Designing Growth Strategies is in our DNA"
Behavioural therapy, also known as psychotherapy, is a term that broadly refers to the treatment that helps alter potentially self-destructing or unhealthy behaviours in a patient. People most commonly seek behavioural therapy to treat depression, anxiety, panic disorders, anger issues, post-traumatic stress disorder (PTSD). It is also used to treat patients suffering from eating disorders, autism, substance abuse, and personality disorders. Increasing prevalence of behavioural disorders, growing awareness and social acceptance of behavioural disorders, clinical advancements in therapy and medication management, increasing awareness about the behavioural therapy are some of the factors that are expected to boost the market growth during the forecast period. According to World Health Organisation, in 2015, the proportion of the global population living with depression was estimated to be 4.4% and is common in females (5.1%) than in males (3.6%).
Rising prevalence of behavioral disorders (depression, anxiety), increasing awareness among people about behavioral therapies, and government initiatives for increasing awareness regarding occurrences of behavioral disorders are some of the factors that are driving the market growth.
However, limited access to mental health care providers, lack of trained medical healthcare providers in emerging regions are some of the factors expected to hamper the growth of behavioral therapy market.
Key Market Driver -
Rising prevalence of behavioral disorders, clinical advancements in therapy management
Key Market Restraint -
Limited access to mental health care providers
By type, the market can be segmented into cognitive behavioral therapy, cognitive behavioral play therapy, systematic desensitization, aversion therapy, and others. By application, the market can be segmented into depression, PTSD (post-traumatic stress disorder), eating disorders, anxiety disorders, substance abuse, ADHD (attention-deficit/ hyperactivity disorder), bipolar disorder, and others. By patient type, the market can be segmented into children and adult. By treatment settings, the market can be segmented into hospitals, outpatient clinics, community health centers, and others.
Geographically, the behavioral therapy market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The major companies in the global behavioural therapy market report includes Magellan Health, Inc., Acadia Healthcare, Universal Health Services, Inc., Springstone, American Addiction Centers, Haven Behavioural Healthcare, Inc., Behavioural Health Group, PEOPLE'S CARE HOLDINGS, INC., and other prominent players.
The global behavioural therapy market is expected to be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global behavioural therapy market due to an increasing prevalence of behavioural disorders (depression, anxiety etc.) in the U.S. According to the National Institute of Mental Health, in 2017, an estimated 17.3 million (7.1%) adults in the United States had at least one major depressive episodes. Also, the availability of advanced healthcare infrastructure and research and development in behavioural therapy are the responsible factors for dominance. Europe is likely to have second-largest market share owing to the rising geriatric population and rising prevalence of behavioural disorders. Asia Pacific and Latin America are expected to register a fast market growth during the forecast period due to the increasing number of behavioural disorders, awareness about behavioural therapies and increased government initiatives for increasing awareness regarding occurrences of behavioural disorders. On the other hand, the Middle East and Africa is projected to surge the behavioural therapy market in the near future because of the increasing social acceptance to behavioural disorders and their prevalence.
To gain extensive insights into the market, Request for Customization
ATTRIBUTE | DETAILS |
By Type |
|
By Application |
|
By Patient Type |
|
By Treatment Settings |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )